Publications

A comprehensive list of all publications by the Urology Health Services Division:

2023

• Large Variations in the Prices of Urologic Procedures at Academic Medical Centers 1 Year After Implementation of the Price Transparency Final Rule

• Utilizing a Questionnaire to Implement a Risk-based Antibiotic Prophylaxis Protocol for Transrectal Prostate Biopsy

• Variation in Statewide Intravesical Treatment Rates for Non-Muscle Invasive Bladder Cancer During the BCG Drug Shortage

• Insurance type and area deprivation are associated with worse overall mortality for patients with muscle-invasive bladder cancer

2022

• Editorial Comment on Diagnostic and Cost Implications of the 2020 AUA Microhematuria Guidelines: Modeling Impact in a Large Public Health Care System

• Large Variation in International Prescribing Rates of Opioids After Robotic Prostatectomy

• The Costs of Delayed Generic Drug Entry: Evidence from a Controversial Prostate Cancer Drug Patent

• Treatment disparities in muscle-invasive bladder cancer: Evidence from a large statewide cancer registry

• Disparities in geographic access to medical oncologists

• Corrigendum to 'The centralization of bladder cancer care and its implications for patient travel distance' [Urologic Oncology: Seminars and Original Investigations volume 39 (2021) 834.e.9-834.e.20/9680]

• Opioid-Free Ureteroscopy: Are Academic Urologists Lagging Behind Private Practice?

• Re: Zachary Klaassen, Emily Vertosick, Andrew J. Vickers, et al. Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.01.041

• Discharge Opioids are Unnecessary Following Radical Cystectomy

• Trends in Urethral Suspension With Robotic Prostatectomy Procedures Following Medicare Payment Policy Changes

• Moving on from Retzius: A Call for Change

• New Mental Health Diagnosis as a Prognostic Factor for Muscle-Invasive Bladder Cancer

• Utility of PSA density in patients with PI-RADS 3 lesions across a large multi-institutional collaborative

2021

• Large reduction in opioid prescribing by a multipronged behavioral intervention after major urologic surgery

• Statewide Price Variation for Generic Benign Prostatic Hyperplasia Medications

• Evaluating the Effectiveness of an Online Journal Club: Experience from the International Urology Journal Club

• Associations Between Female Sex and Treatment Patterns and Outcomes for Muscle-invasive Bladder Cancer

• Diffusion and adoption of the surgical robot in urology

• Referral pattern for urologic malignancies before and during the COVID-19 pandemic

• EDITORIAL COMMENT on Discharge opioid prescription patterns after kidney cancer surgery

• EDITORIAL COMMENT on Preventing Prostate Biopsy Complications: to Augment or to Swab?

• Marked Increase in Sales of Erectile Dysfunction Medication During COVID-19

• Preventing Prostate Biopsy Complications: to Augment or to Swab?

• Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic

• High-intensity end-of-life care among Medicare beneficiaries with bladder cancer

• Incorporating palliative care principles to improve patient care and quality of life in urologic oncology

• The EAU Live Surgery Quagmire: Ethically Questionable and Poorly Tracked

• Institutional Opioid Prescription Guidelines are Effective in Reducing Post-Operative Prescriptions Following Urologic Surgery: Results From the American Urologic Association 2018 Census

• The centralization of bladder cancer care and its implications for patient travel distance

2020

• Anchoring to Zero Exposure: Opioid-free Minimally Invasive Surgery

• Editorial Comment on Opioid Use after Radical Prostatectomy: Nationwide, Population Based Study in Sweden

• Opium Wars to the Opioid Epidemic: The Same Narcotics Cause Addiction and Kill

• The Influence of Stereotactic Body Radiation Therapy Adoption on Prostate Cancer Treatment Patterns

• The Safety and Short-term Outcomes of Leukocyte Depleted Autologous Transfusions During Radical Cystectomy

• Under Treatment of Prostate Cancer in Rural Locations

• Patterns of stereotactic body radiation therapy: The influence of lung cancer treatment on prostate cancer treatment

• A Radical Proposition: Opioid-sparing Prostatectomy

• Editorial Comment on A Nationally Representative Study of Nonindex Hospital Readmissions following Radical Prostatectomy: Implications for Bundled Payment Models

• Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance

• Resurrecting immortal-time bias in the study of readmissions

• The Development and Validation of Prostate Cancer-specific Physician-Hospital Networks

• Decrease in Urologic Discharge Opioid Prescribing after Mandatory Query of Statewide Prescription Drug Monitoring Program

• Don't Be a Luddite: Urologists Benefit from Social Media

• Gender Gap in Industry Relationships and Scholarly Impact Among Academic Urologists in the United States

• How to Use Social Media in Urologic Practice

• Referral pattern for urologic malignancies before and during the COVID-19 pandemic

• Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer

• Comparison of readmission and early revision rates as a quality metric in total knee arthroplasty using the Nationwide Readmission Database

• Strong Conflict of Interest Policies are not Associated With Decreased Industry Payments to Academic Urology Departments

• Increasing use of positron emission tomography among medicare beneficiaries undergoing radical cystectomy

• Radiation oncologists' attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancer

• Reframing Financial Incentives Around Reducing Readmission After Radical Cystectomy

• Clinical Trials in Urology: Predictors of Successes and Failures

• Concordance of confirmatory prostate biopsy in active surveillance with national guidelines: An analysis from the multi-institutional PURC cohort

• The Shrinking Grey Zone of Postoperative Narcotics in the Midst of the Opioid Crisis: The No-opioid Urologist

• EDITORIAL COMMENT on Performance of multiparametric MRI of the prostate in biopsy naive men: A meta-analysis of prospective studies

2019

• Excessive Opioid Prescribing After Major Urologic Procedures

• Concentration of Opioid-Related Industry Payments in Opioid Crisis Areas

• Editorial Comment on Utilization of Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages

• Extreme Price Variation for Generic Benign Prostatic Hyperplasia Medications

• Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries With Bladder Cancer: A SEER-Medicare Analysis

• Role of Post-Acute Care on Hospital Readmission After High-Risk Surgery

• The American Opioid Crisis: The Inexorable March to Death and Addiction

• Small cell bladder cancer: should we consider prophylactic cranial irradiation?

• Association Between Hospital Participation in Medicare Shared Savings Program Accountable Care Organizations and Readmission Following Major Surgery

• Palliative care use amongst patients with bladder cancer

• Downstream Studies Following the Use of Bone Scan in the Staging of Muscle-invasive Bladder Cancer

• E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer

• Increasing Utilization of Multiparametric Magnetic Resonance Imaging in Prostate Cancer Active Surveillance

• Change in Functional Status After Prostate Cancer Treatment Among Medicare Advantage Beneficiaries

• The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement

• Evaluation of the Risks and Benefits of Computed Tomography Urography for Assessment of Gross Hematuria

• Inaugural Readmission Penalties for Total Hip and Total Knee Arthroplasty Procedures Under the Hospital Readmissions Reduction Program

• Spillover Effects of the Hospital Readmissions Reduction Program on Radical Cystectomy Readmissions

• Characterising 'bounce-back' readmissions after radical cystectomy

• Implications of Cystectomy Travel Distance for Hospital Readmission and Survival

• Reversal of the Warburg phenomenon in chemoprevention of prostate cancer by sulforaphane

• Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer

2018

• Evidence-Based Reporting: A Method to Optimize Prostate MRI Communications With Referring Physicians

• The Comparative Effectiveness of Treatments for Ureteropelvic Junction Obstruction

• Challenges in the Analysis of Outcomes for Surgical Compared to Radiotherapy Treatment of Prostate Cancer

• Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care

• Active surveillance for prostate cancer

• Expanded criteria for active surveillance in prostate cancer: a review of the current data

• The comparative effectiveness of quadratus lumborum blocks and paravertebral blocks in radical cystectomy patients

• Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly

• Physician Reimbursement for Prostate Biopsies Falls as Procedures Shift From Offices to Facilities

• Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer

• Manufacturing and the Market: Rationalizing the Shortage of Bacillus Calmette-Guérin

• Effect of multimodal analgesia with paravertebral blocks on biochemical recurrence in men undergoing open radical prostatectomy

• Evaluation of Vasectomy Trends in the United States

• Predictors and Cost of Readmission in Total Knee Arthroplasty

• The Fate of Radical Cystectomy Patients after Hospital Discharge: Understanding the Black Box of the Pre-readmission Interval

• Cost-Effectiveness of Single Versus Confirmatory Urinalysis in the Evaluation of Asymptomatic Microhematuria*

• Risk of Radiation from Computerized Tomography Urography in the Evaluation of Asymptomatic Microscopic Hematuria

• The United States opioid epidemic: a review of the surgeon's contribution to it and health policy initiatives

2017

• Editorial Comment* on Accountable care organizations and prostate cancer care

• The use of intraoperative cell salvage in urologic oncology

• The Relationship of Industry Payments to Prescribing Behavior: A Study of Degarelix and Denosumab

• Cost Analysis of Treatments for Ureteropelvic Junction Obstruction

• Variation in the Use of Open Pyeloplasty, Minimally Invasive Pyeloplasty, and Endopyelotomy for the Treatment of Ureteropelvic Junction Obstruction in Adults

• Ensuring Access to Injectable Generic Drugs - The Case of Intravesical BCG for Bladder Cancer

• Epidemiology of the Small Renal Mass and the Treatment Disconnect Phenomenon

• Variations in Preoperative Use of Bone Scan Among Medicare Beneficiaries Undergoing Radical Cystectomy

• No Differences in Population-based Readmissions After Open and Robotic-assisted Radical Cystectomy: Implications for Post-discharge Care

• Variation in readmission expenditures after high-risk surgery

• Comparative effectiveness in urology: a state of the art review utilizing a systematic approach

• Editorial Comment: Industry Payments to Urologists in 2014: an Analysis of the Open Payments Program

• Payments to Pediatricians in the Sunshine Act

• Preoperative immunonutrition prior to radical cystectomy: a pilot study

• The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer

• Marketing and Testosterone Treatment in the USA: A Systematic Review

• Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam Therapy

• The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide

• Variation in Use of Prostate Biopsy Following Changes in Prostate Cancer Screening Guidelines

2016

• Panniculectomy and Cystectomy: An Approach to the Morbidly Obese Patient

• A Model to Optimize Followup Care and Reduce Hospital Readmissions after Radical Cystectomy

• Urology Payments from Industry in the Sunshine Act

• Association of functional status and treatment choice among older men with prostate cancer in the Medicare Advantage population

• A Generalized Assessment of the Impact of Regionalization and Provider Learning on Patient Outcomes

2015

• Receipt of best care according to current quality of care measures and outcomes in men with prostate cancer

• Radical versus partial nephrectomy

• Understanding hospital readmission intensity after radical cystectomy

• Local coverage determination policy and the use of stereotactic body radiation therapy for prostate cancer

2014

• The impact of technology diffusion on treatment for prostate cancer

• Intensity-modulated radiation therapy for prostate cancer

• Regional variation in quality of prostate cancer care

• Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer

• Adherence to performance measures and outcomes among men treated for prostate cancer

• Technology diffusion and prostate cancer quality of care

All journals we have been published in:

• AJR. American Journal of Roentgenology
• Annals of Surgery
• Annals of Translational Medicine
• BJU International
• BMC Health Services Research
• Cancer
• Carcinogenesis
• Case Reports in Urology
• Clinical Genitourinary Cancer
• Clinical Pediatrics
• Current Opinion in Urology
• European Journal of Cancer Care
• European Urology
• European Urology Focus
• Health Affairs (Project Hope)
• Health Services Research
• In Vivo
• International braz j urol : Official Journal of the Brazilian Society of Urology
• JAMA Network Open
• Journal of Endourology
• Medical Care
• Medical Decision Making : an International Journal of the Society for Medical Decision Making
• Nature Reviews. Urology
• Reviews in Urology
• The Canadian Journal of Urology
• The Journal of Arthroplasty
• Journal of General Internal Medicine
• The Journal of Surgical Research
• The Journal of Urology
• The New England Journal of Medicine
• The Prostate
• The Urologic Clinics of North America
• Translational Andrology and Urology
• Urologic Oncology
• Urology
• Urology Practice